Article
CCAAT/enhancer binding protein β-deficiency enhances type 1 diabetic bone phenotype by increasing marrow adiposity and bone resorption.
American journal of physiology. Regulatory, integrative and comparative physiology - 1 May 2011
Motyl Katherine J, Raetz Michelle, Tekalur Srinivasan Arjun, Schwartz Richard C, McCabe Laura R
Abstract excerpt
Bone loss in type 1 diabetes is accompanied by increased marrow fat, which could directly reduce osteoblast activity or result from altered bone marrow mesenchymal cell lineage selection (adipocyte vs. osteoblast). CCAAT/enhancer binding protein beta (C/EBPβ) is an important regulator of both adipocyte and osteoblast differentiation. C/EBPβ-null mice have delayed bone formation and defective lipid accumulation in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
